LabCorp Announces 2019 Third Quarter Results and Updates 2019 Guidance

Q3 revenue of $2.9 billion , up 3.4% over $2.8 billion last year Q3 diluted EPS of $2.25 , down from $3.10 last year, which included the net gain on the disposition of the Food Solutions business of $1.22 per share Q3 adjusted EPS of $2.90 , up 5.8% over $2.74 last year Q3 free cash flow of $363

LabCorp Expands Services in Northwest Indiana and Surrounding Region Through Acquisition of Diagnostic Clinical Laboratory Assets From South Bend Medical Foundation

 South Bend Medical Foundation and LabCorp Also Establish Pathology Services Collaboration to Serve Customers and Patients Across Four States BURLINGTON, N.C. --(BUSINESS WIRE)--Oct. 22, 2019-- LabCorp® (NYSE: LH), a leading global life sciences company that is deeply integrated in guiding patient

HealthEC, LabCorp, and The New Jersey Primary Care Association Announce Strategic Collaboration to Advance Value-Based Care at Community Health Centers

Agreement Establishes Database and Information Exchange Platform to Facilitate Care-Delivery Collaboration Between Participating New Jersey FQHCs Through LabCorp’s Care Intelligence Module BURLINGTON, N.C. & EDISON, N.J. & HAMILTON, N.J. --(BUSINESS WIRE)--Oct.

LabCorp Celebrates 50 Years of Improving Health, Improving Lives

BURLINGTON, N.C. --(BUSINESS WIRE)--Oct. 15, 2019-- LabCorp® (NYSE: LH), a leading global life sciences company that is deeply integrated in guiding patient care, today announced that it will mark its 50th anniversary at a celebration Oct. 15 in Burlington, North Carolina , where the company has

Conversion Right Triggered for LabCorp’s Zero Coupon Convertible Subordinated Notes Due 2021

BURLINGTON, N.C. --(BUSINESS WIRE)--Oct. 14, 2019-- LabCorp® (NYSE: LH) announced today that its Zero Coupon Convertible Subordinated Notes due 2021 (Zero Coupon Notes) may be converted as set forth below. The Zero Coupon Notes are convertible into cash and Common Stock of LabCorp, if any, subject